18.8K
Downloads
118
Episodes
Tales from the Heart is a unique collection of educational, inspirational, and enlightening discussions with the stakeholders in the field of cardiology that come straight from the heart. The guests are patients, physicians, healthcare professionals, industry leaders, state and federal regulators and legislators, journalists, and more. Each story delves into the world of the Hypertrophic Cardiomyopathy Associations network and uncovers the true face of HCM from every angle. Patients will inspire you, medical professionals will educate you, and we may even motivate you to learn more and get involved. In season two Tales welcomes new regular co-host including, Dr. Martin Maron, Dr. Harry Lever, Dr Steve Ommen, Dr. Alex de Feria and more!
Episodes
Wednesday Oct 28, 2020
Wednesday Oct 28, 2020
In this episode, Lisa talks with Dr. Harry Lever of Cleveland Clinic for a discussion about invasive therapy for obstruction. We take a deep dive in to "when" to think about getting moving to myectomy or alcohol septal ablation. Dr. Lever also talks about the various treatments for obstruction. Q&A included.
Tuesday Oct 13, 2020
Tuesday Oct 13, 2020
In this episode of Tales from the Heart, Lisa talks to Dr. Martin Maron, the Director of the Hypertrophic Cardiomyopathy Center at Tufts Medical Center and Associate Professor at Tufts University School of Medicine. His specialties include cardiac imaging, hypertrophic cardiomyopathy, and cardiac magnetic resonance imaging. In this episode Dr. Maron talks about cardiac imaging in HCM, the history of HCM treatment and diagnosis, the purpose and usefulness of an echocardiogram, contrast echocardiogram, normal values for wall thickness, obstruction, heart murmur, cardiac MRI, and more.
Friday Oct 02, 2020
Friday Oct 02, 2020
In this episode, Lisa talks with Dr. Harry Lever of Cleveland Clinic about safety concerns with some generic drugs. He advises listeners to stay informed about where medication by checking the label and asking your pharmacist. There are documented cases of quality and purity problems coming from some overseas manufacturing plants.